PT-141 10mg

PT-141 (bremelanotide) is a synthetic heptapeptide analogue of α-MSH that acts on MC3R and MC4R melanocortin receptors in the central nervous system. Unlike PDE5 inhibitors, which work through vascular mechanisms, research suggests PT-141 engages the brain's arousal pathways directly — a distinct pharmacological class. Bremelanotide has been extensively investigated in clinical trials and is the basis for a prescription medication (Vyleesi) approved for a specific clinical population — a separate, regulated product distinct from research-grade compounds sold here. For in-vitro and laboratory research use only.